NANOSPEED DIAGNOSTICS INC.

NanoSpeed Diagnostics Inc., founded in 2009 and based in Edmonton, Alberta, specializes in the development and manufacturing of proprietary point-of-care diagnostic screening test kits. The company utilizes Lateral Flow Immuno-Assay (LFIA) and lab-on-a-chip technologies to create rapid, quantitative, and qualitative diagnostic tools. Its flagship product, Test4D, was developed as the world’s first point-of-care test for Vitamin D deficiency. The company operates a dedicated manufacturing and R&D facility in the Edmonton Research Park, which holds ISO 13485 MDSAP certification. Beyond its core vitamin and mineral tests, which include panels for Ferritin, Vitamin B12, and Vitamin A, NanoSpeed is exploring advanced diagnostics, including AI-assisted analysis of blood samples.

These diagnostic solutions are designed to provide cost-effective, reliable, and accessible testing tools for healthcare professionals, clinical settings, and consumers. By enabling rapid health assessments from a single drop of blood, NanoSpeed addresses critical gaps in preventive care and remote monitoring. The company has successfully scaled its operations to reach global markets, with its products sold internationally through distribution networks serving hospitals, pharmacies, and clinics. NanoSpeed’s ongoing innovations, including regulatory-approved test kits and R&D into detection for markers like THC, demonstrate its commitment to advancing point-of-care technology and improving patient health outcomes.